A study using factor VIIa inhibitor in combination with GEM showed a nonsignificant trend toward longer progression-free survival in patients with cancer ( 72 ).
← all excerpts
Reactive myelopoiesis and FX-expressing macrophages triggered by chemotherapy promote cancer lung metastasis.
1
—
—